VOR
Vor Biopharma Inc. · Healthcare · Market cap $1.1B
Insiders sold $4K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Jul 21, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$66.0M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Oct 5, 2026
RA CAPITAL MANAGEMENT, L.P.
Vor Biopharma Inc. (VOR) has 12 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 5, 2026.
Inside the rolling window, 1 insider at Vor Biopharma Inc. reported no open-market purchases and 18 open-market sales totaling $66.0M. The most active filer is 10% Owner RA CAPITAL MANAGEMENT, L.P. with 18 filings. Insiders have net sold $34.9M over the trailing 6 months. The most recent open-market filing is a sale of 213 shares by 10% Owner RA CAPITAL MANAGEMENT, L.P., dated Jul 16, 2026, worth $4K.
- Industry:Biotechnology
- CEO:Jean-Paul Kress
- Employees:76
- HQ:Boston, MA, US
- IPO:2021-02-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Sale | 213 | $4K | Jul 21 | -5.5% | SEC ↗ | |
| Director, 10% Owner | Sale | 165,150 | $2.6M | Apr 24 | +37.1% | SEC ↗ | |
| Director, 10% Owner | Sale | 458,411 | $7.5M | Apr 21 | +24.9% | SEC ↗ | |
| Director, 10% Owner | Sale | 171,963 | $2.7M | Apr 21 | +24.9% | SEC ↗ | |
| Director, 10% Owner | Sale | 530,610 | $8.6M | Apr 15 | +21.4% | SEC ↗ | |
| Director, 10% Owner | Sale | 153,735 | $2.5M | Apr 15 | +21.4% | SEC ↗ | |
| Director, 10% Owner | Sale | 53,644 | $859K | Apr 15 | +21.4% | SEC ↗ | |
| Director, 10% Owner | Sale | 484,104 | $8.0M | Apr 10 | +22.4% | SEC ↗ | |
| Director, 10% Owner | Sale | 135,201 | $2.2M | Apr 10 | +22.4% | SEC ↗ | |
| Director, 10% Owner | Sale | 828 | $13K | Apr 10 | — | SEC ↗ | |
| Director, 10% Owner | Sale | 260,000 | $4.7M | Apr 6 | — | SEC ↗ | |
| Director, 10% Owner | Sale | 589,257 | $9.8M | Apr 6 | — | SEC ↗ | |
| Director, 10% Owner | Sale | 124,311 | $3.4M | Oct 30 | — | SEC ↗ | |
| Director, 10% Owner | Sale | 251,518 | $6.3M | Oct 30 | — | SEC ↗ | |
| Director, 10% Owner | Sale | 24,579 | $617K | Oct 30 | — | SEC ↗ | |
RA CAPITAL MANAGEMENT, L.P.First filing | Director, 10% Owner | Sale | 76,880 | $2.2M | Oct 27 | — | SEC ↗ |
RA CAPITAL MANAGEMENT, L.P.First filing | Director, 10% Owner | Sale | 53,345 | $1.5M | Oct 27 | — | SEC ↗ |
RA CAPITAL MANAGEMENT, L.P.First filing | Director, 10% Owner | Sale | 90,941 | $2.6M | Oct 27 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does VOR have?
Vor Biopharma Inc. (VOR) has 12 SEC Form 4 filings (27 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 5, 2026.
When was the most recent SEC Form 4 filing for VOR?
The most recent Form 4 filing for VOR on Tracefour is dated Oct 5, 2026.
Who is the most active insider at VOR?
The most active SEC Form 4 filer at VOR in the rolling window is 10% Owner RA CAPITAL MANAGEMENT, L.P., with 18 filings.
What is the net insider flow at VOR over the last 6 months?
Over the trailing 180 days, insiders at VOR have net sold $34.9M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VOR in the current window?
Inside the rolling window, insiders at VOR bought $0 and sold $66.0M based on SEC Form 4 filings.
Can I get alerts for VOR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Vor Biopharma Inc. (VOR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Vor Biopharma Inc. is in the Healthcare sector.